Fortress Biotech
FBIO
36 hedge funds and large institutions have $18.5M invested in Fortress Biotech in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 10 closing their positions.
321% more call options, than puts
Call options by funds: $846K | Put options by funds: $201K
14% more capital invested
Capital invested by funds: $16.3M → $18.5M (+$2.22M)
8% less funds holding
Funds holding: 39 → 36 (-3)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$1.13M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$359K |
| 3 |
SIM
Spark Investment Management
New York
|
+$73.8K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$34.9K |
| 5 |
Jane Street
New York
|
+$24.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$394K |
| 2 |
Goldman Sachs
New York
|
-$257K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$252K |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$196K |
| 5 |
ACM
Advent Capital Management
New York
|
-$187K |
FBIO Hedge Fund Activity: Q4 2014 in Review
36 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2014, worth a combined $18.5M — up 14% from $16.3M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of FBIO and 7 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 8 added.
The largest buyer was Invesco, opening a new position worth an estimated $1.13M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $394K sold.
- 36 institutional investors held Fortress Biotech (FBIO) as of Q4 2014, down from 39 in Q3 2014.
- Funds reported $18.5M of Fortress Biotech stock for Q4 2014, up 14% quarter-over-quarter.
- 7 funds opened new Fortress Biotech positions in Q4 2014 and 10 closed out, a net change of -3 holders.
- The largest Fortress Biotech buyer in Q4 2014 was Invesco, an estimated $1.13M added.
- The largest Fortress Biotech seller in Q4 2014 was Renaissance Technologies, an estimated $394K sold.
Based on aggregated 13F filings for Q4 2014.